Health Wealth Fund One Series 3 LLC has made a significant move by filing an amendment regarding its securities offering. This action, recorded on October 21, 2026, is crucial for the company as it seeks to strengthen its fundraising strategies and ensure compliance with regulatory requirements.
Background
Health Wealth Fund One Series 3 LLC is classified under the entity type of 'other'. It operates in the financial sector, focusing on investment strategies and fundraising initiatives. The company has been active in filing various documents with the SEC, with its most recent filings including multiple amendments to its securities offerings.
What the Filing Says
The recent filing, identified by accession number 0002128347-26-000009, indicates an amendment to an exempt offering of securities. The filing states, "Effectiveness Date: 2026-10-21," confirming that the amendment is now in effect.
Impact
This update may affect potential investors and stakeholders interested in Health Wealth Fund One Series 3 LLC. By amending its securities offering, the company aims to attract more investment while adhering to regulatory standards. This move could also influence similar firms in the financial sector as they navigate their own fundraising efforts.
What's Next
The filing does not say what happens next.
Company Information
Health Wealth Fund One Series 3 LLC is registered with the Central Index Key (CIK) number 0002128347 and operates under the Employer Identification Number (EIN) 413999203. The company is incorporated in Delaware and has a fiscal year ending on December 31.
Filing Details
This amendment, classified as Form D/A, was accepted on the same day it was filed, October 21, 2026, at 13:37:02. The filing includes one document, which can be accessed through the SEC's EDGAR database.
Contact Information
The business and mailing address for Health Wealth Fund One Series 3 LLC is 3472 Research Parkway, Ste 104, PMB171, Colorado Springs, CO 80920. The company can be reached at the phone number 412-337-5254.
Additional Insights
The filing does not provide specific details regarding the terms of the securities being offered or the intended use of the proceeds from the offering. Furthermore, it does not disclose any information about the company's financial performance or investment strategies that may be relevant to potential investors.